EML4-ALK fusion protein in Lung cancer cells enhances venous thrombogenicity through the pERK1/2-AP-1-tissue factor axis.

Su, Yanping; Yi, Jiawen; Zhang, Yuan; Leng, Dong; Huang, Xiaoxi; Shi, Xinyu; Zhang, Yuhui

Su, Yanping; Yi, Jiawen; Zhang, Yuan; Leng, Dong; Huang, Xiaoxi; Shi, Xinyu; Zhang, Yuhui.

Affiliation

Su Y; Department of Respiratory and Critical Care Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, 100020, China.
Yi J; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Zhang Y; Department of Respiratory and Critical Care Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, 100020, China.
Leng D; Department of Respiratory and Critical Care Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, 100020, China.
Huang X; Clinical Laboratory, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, 100020, China.
Shi X; Basic Medical Research Center, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, 100020, China.
Zhang Y; Department of Respiratory and Critical Care Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, 100020, China. shixinyusxy@126.com.

J Thromb Thrombolysis ; 57(1): 67-81, 2024 Jan.

Article de En | MEDLINE | ID: mdl-37940761

Sujet(s)
Mots clés

EML4-ALK fusion protein; Tissue factor; Venous thromboembolism

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Carcinome pulmonaire non à petites cellules / Tumeurs du poumon Limites: Animals / Humans Langue: En Journal: J Thromb Thrombolysis Sujet du journal: ANGIOLOGIA Année: 2024 Type de document: Article Pays d'affiliation: Chine Pays de publication: Pays-Bas

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google